Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Ionis Pharmaceuticals Inc | 832 |
| 2 | Harvard University | 693 |
| 3 | Life Technologies Corp | 646 |
| 4 | University of California, San Diego | 358 |
| 5 | Massachusetts Institute of Technology | 325 |
| 6 | Sequenom Inc | 273 |
| 7 | Applied Biosystems Inc | 251 |
| 8 | Applied Biosystems LLC | 250 |
| 9 | Oxford Nanopore Technologies PLC | 225 |
| 10 | University of California Berkeley | 170 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 10,661 |
| 2 | A61K | Medicinal preparations | 9,340 |
| 3 | A61P | Therapeutic activity (drug indications) | 8,198 |
| 4 | C12Q | Measuring/testing involving enzymes | 6,905 |
| 5 | C07K | Peptides | 5,403 |
| 6 | C07H | Sugars and derivatives | 3,352 |
| 7 | G01N | Investigating / analysing materials | 2,809 |
| 8 | C12Y | Enzyme nomenclature (EC numbers) | 2,350 |
| 9 | C07D | Heterocyclic compounds | 1,438 |
| 10 | C12P | Fermentation, enzyme processes | 1,370 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis | 1994 | Scripps Research Institute | 62 |
| Method for the production of 2'-deoxyadenosine compounds | 1988 | Brigham Young University | 38 |
| Method for the production of 2'-deoxyadenosine compounds | 1986 | Brigham Young University | 36 |
| 2-halo-2'-deoxyadenosines in the treatment of monocyte-mediated inflammatory disease conditions | 1996 | Scripps Research Institute | 24 |
| 2-Halo-2'-deoxyadenosines as therapeutic agents against malignant astrocytoma | 1995 | Scripps Research Institute | 19 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | DNA and Nucleic Acid Chemistry | 2 |
| 2 | Pharmaceutical and Antibiotic Environmental Impacts | 1 |
| 3 | Sperm and Testicular Function | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Arun R. Wakade | Wayne State University | 6 |
| 2 | Erik De Clercq | Rega Institute for Medical Research | 6 |
| 3 | Jayant S Kulkarni | Wayne State University | 6 |
| 4 | Jean Cadet | CEA Grenoble | 6 |
| 5 | Azusa Suzuki | Nihon University | 5 |
| 6 | Leif Krönberg | Åbo Akademi University | 5 |
| 7 | Ashok Agarwal | Cleveland Clinic | 4 |
| 8 | Bolesław T. Karwowski | Medical University of Lodz | 4 |
| 9 | Jan Balzarini | Rega Institute for Medical Research | 4 |
| 10 | Alejandro B. Sigue | Soliman Fakeeh Hospital | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| <i>Staphylococcus aureus</i> Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death | 2013 | 410 | Immune cells in cancer |
| Phosphorothioation of DNA in bacteria by dnd genes | 2007 | 274 | RNA and protein synthesis mechanisms |
| N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA | 2020 | 248 | Epigenetics and DNA Methylation |
| Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates | 2019 | 248 | Cancer-related molecular mechanisms research |
| Peroxynitrite Mediated Oxidation of Purine Bases of Nucleosides and Isolated DNA | 1996 | 178 | Nitric Oxide and Endothelin Effects |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of deoxyadenosine?
Which organizations hold the most patents mentioning deoxyadenosine?
What types of therapeutic applications have been patented for deoxyadenosine derivatives?
What research topics are most prominent in the academic literature on deoxyadenosine?
How has patenting activity for deoxyadenosine changed in recent years?